0.68 - 0.75
0.33 - 0.86
12.91M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.49%
Negative revenue growth while 0335.HK stands at 329.04%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-5.93%
Negative gross profit growth while 0335.HK is at 329.04%. Joel Greenblatt would examine cost competitiveness or demand decline.
-38.09%
Negative EBIT growth while 0335.HK is at 238.31%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-38.09%
Negative operating income growth while 0335.HK is at 6.00%. Joel Greenblatt would press for urgent turnaround measures.
-46.61%
Negative net income growth while 0335.HK stands at 903.44%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-58.14%
Negative EPS growth while 0335.HK is at 928.04%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-58.14%
Negative diluted EPS growth while 0335.HK is at 928.04%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
27.41%
Slight or no buybacks while 0335.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
27.49%
Diluted share change of 27.49% while 0335.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-60.86%
Negative OCF growth while 0335.HK is at 31.40%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-86.70%
Negative FCF growth while 0335.HK is at 31.42%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
60253.69%
10Y revenue/share CAGR above 1.5x 0335.HK's 599.17%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-22.50%
Negative 5Y CAGR while 0335.HK stands at 9.07%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-3.23%
Negative 3Y CAGR while 0335.HK stands at 141.09%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
1252.02%
10Y OCF/share CAGR above 1.5x 0335.HK's 544.54%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
382.08%
5Y OCF/share CAGR above 1.5x 0335.HK's 201.22%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
1336.12%
3Y OCF/share CAGR under 50% of 0335.HK's 5256.16%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
334.84%
Net income/share CAGR at 50-75% of 0335.HK's 547.53%. Martin Whitman might question if the firm’s product or cost base lags behind.
115.27%
Below 50% of 0335.HK's 501.99%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
911.33%
3Y net income/share CAGR above 1.5x 0335.HK's 502.03%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
326.15%
5Y equity/share CAGR above 1.5x 0335.HK's 63.22%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
52.13%
3Y equity/share CAGR 1.25-1.5x 0335.HK's 41.33%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Negative near-term dividend growth while 0335.HK invests at 60.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-14.25%
Firm’s AR is declining while 0335.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
19.80%
Inventory growth of 19.80% while 0335.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-6.28%
Negative asset growth while 0335.HK invests at 19.85%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-19.68%
We have a declining book value while 0335.HK shows 31.14%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-40.86%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-10.61%
Our R&D shrinks while 0335.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.66%
SG&A declining or stable vs. 0335.HK's 8.92%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.